The genomics of response to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer - results from the ACOSOG Z1041 (Alliance) trial
- Citation:
- Meeting Instance:
- PCC 2016
- Year:
- 2016
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Note:
- http://pccradiumhospital.org/content/text_8ef111f1-5736-4092-8487-6601340066bb/1456755424010/pcc2016_a5.pdf
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 2611
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10CA76001, K22CA188163, 5U54HG003079
- Corr. Author:
- Authors:
- Robert Lesurf Obi Griffith Malachi Griffith Lee Trani Mark A. Watson Matthew J. Ellis David Ota Vera J. Suman Funda Meric-Bernstam A. Marilyn Leitch Judy C. Boughey Gary Unzeitig Aman U. Buzdar Kelly K. Hunt Elaine R. Mardis
- Networks:
- LAPS-MN026, LAPS-MO011, LAPS-TX011, LAPS-TX035, TX041, TX190
- Study
- ACOSOG-Z1041
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: